Get started
Author

Altar Ozbıyık

Observed name: Altar Ozbiyik
ORCID: 0009-0004-8908-7444
Observed ORCID: 0009-0004-8908-7444
OpenAlex ID: A5117527033
Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma
2025 · Ezgi Yagmur Kala, Filiz Senbabaoglu Aksu, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
DDRKOL: A Focused CRISPR Library for Systematic Identification of DNA Damage Response Dependencies in Glioblastoma
2026 · Canan Bayraktar-Odabas, Ipek Kok, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
5064 Integrated focused CRISPR screens reveal new modulators of radiotherapy response across diverse glioma subtypes
2026 · Nareg Degirmenci, Altar Ozbiyik, et al. · Radiotherapy and Oncology
4749 Evaluation of the Effect of Anti-Interleukin-6 Receptor Antibodies on Radiation-Induced Lung Injury in a Murine Model
2026 · Merve Duman, Pinar Bulutay, et al. · Radiotherapy and Oncology
4416 Inhibitors of the enzyme Arginine Methyltransferase (PRMT) are identified as radiosensitizers in glioblastoma cells through a chemical screen
2025 · Beyza Nur Koseoglu, Nareg Pınarbası-Degirmenci, et al. · Radiotherapy and Oncology
Works count: 5
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type